+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID00515567

Using Explanted Lungs to Study Pulmonary Fibrosis by Analyzing Tissue Samples and Cell Lines

Led by University of Chicago · Updated on 2026-01-13

90

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Pulmonary Fibrosis is a condition where lung tissue becomes scarred and thickened, reducing the lungs ability to transfer oxygen to the blood. Researchers aim to study this process at the cellular level by comparing lung tissue from patients with pulmonary fibrosis to those without the disease. This observational study is designed to increase understanding of the causes of pulmonary fibrosis using explanted lung tissues. The study involves collecting lung tissue samples from patients who are undergoing lung transplant surgery. These samples will be used to isolate cells such as fibroblasts and analyze cytokines associated with pulmonary fibrosis. There are no study drugs or treatments given, as this is an observational study focused on tissue analysis. Participants will be patients awaiting lung transplant surgery who agree to provide consent for their lung tissue to be used in research. Researchers will assess the cellular components involved in pulmonary fibrosis and measure specific markers related to the disease. The study is sponsored by the University of Chicago and aims to improve knowledge about pulmonary fibrosis through detailed tissue studies. Participation involves tissue donation and data collection related to the lung samples.

CONDITIONS

Brief Title

Explanted Lung Tissues With Pulmonary Fibrosis

Research Team

N

Nickolai Dulin, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here